AN INVITRO MODEL FOR TUMOR-IMMUNOTHERAPY WITH ANTIBODY HETEROCONJUGATES

被引：44

作者：

JUNG, G ^{[1
]}

EBERHARD, HJM ^{[1
]}

机构：

[1] SCRIPPS CLIN & RES FDN,RES INST,DEPT IMMUNOL,LA JOLLA,CA 92037

来源：

IMMUNOLOGY TODAY | 1988年 / 9卷 / 09期

关键词：

D O I：

10.1016/0167-5699(88)91304-7

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：257 / 260

页数：4

共 55 条

[41]

RITZ J, 1981, BLOOD, V58, P141

[42]

SCHROFF RW, 1985, J NATL CANCER I, V74, P299

[43] TUMOR IMAGING AND DRUG TARGETING [J].

SIKORA, K ;

SMEDLEY, H ;

THORPE, P .

BRITISH MEDICAL BULLETIN, 1984, 40 (03) :233-+

[44] T-CELL ACTIVATION BY ANTI-T3 ANTIBODIES - COMPARISON OF IGG1 AND IGG2B SWITCH VARIANTS AND DIRECT EVIDENCE FOR ACCESSORY FUNCTION OF MACROPHAGE FC-RECEPTORS [J].

SMITH, KGC ;

AUSTYN, JM ;

HARIRI, G ;

BEVERLEY, PCL ;

MORRIS, PJ .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (05) :478-486

[45] HYBRID ANTIBODIES CAN TARGET SITES FOR ATTACK BY T-CELLS [J].

STAERZ, UD ;

KANAGAWA, O ;

BEVAN, MJ .

NATURE, 1985, 314 (6012) :628-631

[46] HYBRID HYBRIDOMA PRODUCING A BISPECIFIC MONOCLONAL-ANTIBODY THAT CAN FOCUS EFFECTOR T-CELL ACTIVITY [J].

STAERZ, UD ;

BEVAN, MJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (05) :1453-1457

[47] CYTOTOXIC LYMPHOCYTE-T-MEDIATED LYSIS VIA THE FC RECEPTOR OF TARGET-CELLS [J].

STAERZ, UD ;

BEVAN, MJ .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1985, 15 (12) :1172-1177

[48] MITOGENIC ACTIONS OF ORTHOCLONE OKT3 ON HUMAN PERIPHERAL-BLOOD LYMPHOCYTES - EFFECTS OF MONOCYTES AND SERUM COMPONENTS [J].

VANWAUWE, J ;

GOOSSENS, J .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1981, 3 (03) :203-208

[49]

VANWAUWE JP, 1980, J IMMUNOL, V124, P2708

[50] IMMUNOTOXINS - A NEW APPROACH TO CANCER-THERAPY [J].

VITETTA, ES ;

KROLICK, KA ;

MIYAMAINABA, M ;

CUSHLEY, W ;

UHR, JW .

SCIENCE, 1983, 219 (4585) :644-650

← 1 2 3 4 5 6 →